Inhibition of cardiac Kv4.3/KChIP2 channels by a sulfonylurea drug gliquidone

IF 3.2 3区医学 Q2 PHARMACOLOGY & PHARMACY

Molecular Pharmacology Pub Date : 2023-12-21 DOI:10.1124/molpharm.123.000787

Chenxia Yang, Qinqin Li, Fang Hu, Yani Liu, KeWei Wang

引用次数: 0

查看原文本刊更多论文

磺脲类药物格列酮对心脏 Kv4.3/KChIP2 通道的抑制作用

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Molecular Pharmacology 医学-药学

CiteScore

7.20

自引率

2.80%

发文量

审稿时长

3-6 weeks

期刊介绍： Molecular Pharmacology publishes findings derived from the application of innovative structural biology, biochemistry, biophysics, physiology, genetics, and molecular biology to basic pharmacological problems that provide mechanistic insights that are broadly important for the fields of pharmacology and toxicology. Relevant topics include: Molecular Signaling / Mechanism of Drug Action Chemical Biology / Drug Discovery Structure of Drug-Receptor Complex Systems Analysis of Drug Action Drug Transport / Metabolism